Pharma Financial Squeeze Bodes Ill for Genomics
Pharma Financial Squeeze Bodes Ill for Genomics ‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general and genomics in particular, according to a panel of leading venture capitalists.
Pharma Financial Squeeze Bodes Ill for Genomics ‘Caution: Tougher Times Ahead’ may be an apt sign for biotech in general and genomics in particular, according to a panel of leading venture capitalists.
DeCode’s Genetic Breakthrough Barely Registers DeCode Genetics published an important genetic map–assembled by methods very different from those used to create the sequence of the human genome–that will make it much easier for scientists to hunt down new genes linked to disease. But DeCode’s stock continues to languish.
Get new actionable insights and updates from BiotechBlog